Kura Oncology (($KURA)) announced an update on their ongoing clinical study. Study Overview: Kura Oncology is conducting a Phase 3 clinical study ...

Cero Therapeutics Holdings, Inc. (($CERO)) announced an update on their ongoing clinical study. Study Overview: Cero Therapeutics Holdings, Inc.

Scientists have discovered how leukemia cells outsmart a leading treatment and may have found a way to stop them. Scientists ...

Researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), have published a ...

The refusal of blood transfusions by Jehovah’s Witnesses poses a major challenge in treating acute myeloid leukaemia (AML), ...

IDH1 inhibitors show strong efficacy and tolerability in IDH1-mutated AML and MDS, with some patients achieving long-term ...

Discusses Clinical Update on AB8939 Combined With Venetoclax for Refractory and Relapsed AML With Poor Genetics October 16, ...

A research team at Lund University in Sweden has discovered a mechanism that helps acute myeloid leukemia cells to evade the body's immune system. By developing an antibody that blocks the mechanism, ...

Ateganosine combined with Libtayo shows improved progression-free survival in advanced non-small cell lung cancer, suggesting potential long-term use. Spevatamig, a bispecific antibody, is being ...

Acute myeloid leukemia (AML) cells under the microscope, in purple. There is a serious need for finding better ways to treat AML that comes back after initial treatment. Chimeric antigen receptor (CAR ...

CAR T-cell therapy works by engineering a patient’s T cells to express synthetic receptors that recognize and kill cancer cells without relying on HLA presentation. This approach has shown remarkable ...